Spectrodensitometric determination of clorazepate dipotassium, primidone and chlorzoxazone each in presence of its degradation product.

Abstract:

:The present work describes a quantitative thin layer procedure for estimating primidone, clorazepate dipotassium and chlorzoxazone in bulk powders and in dosage forms, each in the presence of its degradation product. The method consists of dissolving the drug in ethanol (for primidone), or methanol (for clorazepate dipotassium and chlorzoxazone) and then spotting this solution on a thin layer of silica gel G254. Quantitation is achieved by comparing the areas under the peaks obtained from scanning the thin layer chromatographic plates in a spectrodensitometer.

journal_name

J Pharm Biomed Anal

authors

El Bayoumi AA,Amer SM,Moustafa NM,Tawakkol MS

doi

10.1016/s0731-7085(98)00043-0

subject

Has Abstract

pub_date

1999-09-01 00:00:00

pages

727-35

issue

5

eissn

0731-7085

issn

1873-264X

pii

S0731-7085(98)00043-0

journal_volume

20

pub_type

杂志文章